Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical Landscape
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers14010044
Abstract: Simple Summary PARP inhibitors (PARPi) are current treatment options for patients with ovarian, breast, pancreatic or prostate cancer. Although PARPi have transformed the patient journey in these disease settings, resistance eventually develops, leaving them with… read more here.
Keywords: parpi; preventing overcoming; clinical landscape; resistance ... See more keywords